Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Supplementary Information
Towards the production of flavone-7-O-β-D-glucopyranosides using
Arabidopsis glycosyltransferase in Escherichia coli
Nguyen Huy Thuan, Je Won Park and Jae Kyung Sohng٭
Department of Pharmaceutical Engineering, Institute of Biomolecule Reconstruction, Sun Moon University, #100,
Kalsan-ri, Tangjeong-myeon, Asan-si, Chungnam 336-708, Republic of Korea
D1. Construction of recombinant strains
E. coli BL21(DE3) (Novagen, Darmstadt, Hesse, Germany) containing UDP-glucose
biosynthetic pathway was utilized for deletion of zwf, pgi and ushA, as well as for combination
with over-expression of galU to generate various types of strains. The reconstruction process
resulted in E. coli BL21(DE3) (control), E. coli BL21(DE3)/∆pgi/galU, E. coli
BL21(DE3)/∆pgi/∆zwf/galU and E. coli BL21(DE3)/∆pgi/∆zwf//∆ushA/galU, which were used
as hosts [18]. All these strains were then transformed with recombinant pFL containing
Arabidopsis GT, to construct whole-cell biocatalysts which were named as strain MAF, MA1F,
MA2F and MA3F (Table 1).
D2. Cloning and expression of recombinant glycosyltransferase in E. coli host
cDNA of A. thaliana glycosyltransferase (RAFL15-41-P03) was purchased from RIKEN
Bioresource Center (NIG, Ibaraki, Japan) [4, 5]. All restriction enzymes and T4 DNA ligase
were obtained from Promega (Fitchburg, WI, USA) and Takara (Otsu, Shiga, Japan).
Oligonucleotide primers (Genotech Ltd., Daejon, Chungnam, South Korea) include 5’-TAC
GGATCC GAAATGGAGCCAAAGTTT-3’ (forward) and 5’-ACA AAGCTT
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
TAATCAAATCAAATTCTC-3’ (reverse) containing recognized sequence of BamHI and
HindIII as restriction sites, respectively. GT was amplified by PCR, and was inserted into
pGEM-T-easy subcloning vector (Promega, Fitchburg, WI, USA) for sequencing. This DNA
fragment was then ligated into the pET32a(+) expression vector to obtain pFL plasmid, and was
finally transformed into E. coli to construct the recombinant host (Table 1).
D3. Media optimization
TB media containing 0.4, 1.0, 1.5 and 2% (w/v) glycerol were used as various media recipes. In
a similar manner, glucose-supplemented TB media with 0, 1, 3 and 5% (w/v) were also utilized
to culture the recombinant E.coli. In contrast, neither glycerol–supplemented nor glucose–added
TB media were used as controls. OD600 was then monitored at intervals of 12h to evaluate the
growth of E. coli.
D4. Extraction, purification and detection methods
The crude extract was obtained by adding of culture broth with 2 volumes of ethyl acetate (v/v =
2:1), stirred and dried by frozen rotary evaporator. The fat content was eliminated by dissolution
in the mixture of hexane and methanol (v/v = 1:5). The presence of the flavone glucosides was
then detected by thin layer chromatography (TLC) using the solvent system: ethyl acetate, water,
methanol and toluene (v/v/v/v = 8:1:1:0.2) in aluminum oxide plate were used as the initial
materials. Substrates and their glucosides were then detected by UV visualization at 280 nm.
They can also be detected as yellow spots by spraying with 10% sulfuric acid, and heating at
110°C for 5 s.
The products were purified in two steps. Firstly, each crude extract was partially fractionized
through a column (2.5 x 50 cm, Pyrex, Incheon, Sutogwon, Korea) filled with normal-phase
silica (Silica gel 60 GF254, Merck, Darmstadt, Hesse, Germany) to obtain target fragment, which
was then checked by TLC. Secondly, it was applied to the prep–HPLC system using an ODS
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
column (2.5 x 25 cm, YMC-Pack ODS-AQ, Tokyo, Japan), and a UV detector at 280 nm. The
harvested fragment was then filtered twice using Whatman® paper (ɸ 0.2nm, Maidstone, Kent,
ME16 LS, England) and was finally freeze-dried.
A HPLC (Shimadzu, Kyoto, Japan) detection method was performed by binary program with
solvent systems, including acetonitrile (100%) as solvent B, and double distilled water (0.1%
formic acid) as solvent A. The program was described as follows: solvent B: 5% in 0–7 min, 5–
30% in 7–15 min, 30–90% in 15–25 min and 90–100% in 25–30 min. The solvent flow rate was
1 mL.min-1 and UV wavelength = 280 nm. The samples were then subjected to
LC-QTOF-ESI/MS (Water, Milford, MA, USA) to determine the mass of apigenin-7-O-
glucoside and baicalein-7-O-glucoside, respectively.
D5. NMR analysis of apigenin-7-O-β-glucoside (APG) and baicalein-7-O-β-glucoside (BCG).
The 1H-NMR spectra displayed a flavonoid pattern and showed signals at δ = 6.83 - 7.02 (1H, s)
6.83-7.07 (1H, s) and 6.46 or 8.6 ppm (1H, s) typical of protons at C-3, C-8 and C-6 of a flavone
core structure. The signal at δ = 12.57 or 12.98 ppm was assigned to the C-5 hydroxyl. 1H-NMR
resonances at δ 3.20 to 3.70 ppm and signals in the 13C-NMR spectrum just below δ = 70 ppm
indicated the presence of a glucose moiety [1]. The signal at δ = 5.15 ppm was assigned to the
anomeric proton (H-1”) with a coupling constant (J = 8.0 Hz) indicating a β-configuration [2]. In
additional, in the HMBC spectrum of APG showing the the cross peak from H-1” (δ = 5.15) to
C-7 (δ = 161.85) confirmed that the glucosylation takes place in the 7-OH position. Similarly,
the cross peak from H-1” (δ = 5.15) to C-7 (δ = 149.68) in the HMBC profile of BCG indicated
the glucosylation in C-7 position in the baicalein molecule [3].
49
50
51
52
53
54
55
56
57
58
5960
61
62
63
64
65
66
67
68
69
70
71
72
Captions
Table S1. Substrate specificity of Arabidopsis glycosyltransferase AGT.
Table S2. (A) 1H NMR profile of APG and BCG, and (B) 13C NMR profile of APG and BCG.
Legends.
Figure S1. Amino acid alignment of putative Arabidopsis GT with relative ones showing the conserved sequence PSPG in the C-terminal domain. (1), (2), (3) and (4) sequences are highly conserved in all the compared GTs.
Figure S2. Dendrogram of deduced amino acid sequence GTs displaying the phylogenetic relationship. NP_001235161.1: Glycine max ; XP_002276981.1: Vitis vinifera, ABR57234.1: Antirrhinum majus ; AAR06919.1: Stevia rebaudiana, ACB56924.1: Hieracium pilosella; BAG31949.1: Perilla frutescens, AAO42032.1: Arabidopsis thaliana, ABS83552.1: Scutellaria baicalensis; BAH19313.1: S. baicalensis, BAG31946.1: S. laeteviolacea; BAH14962.1: Torenia hybrid cultivar; AAL40272.1: Jatropha curcas; BAE48240.1: Linaria vulgaris. UGT1A3: Homo sapien; NP_066307.1: Homo sapien; AAS41089.1: Bacillus cereus; ABA42119.2: Streptomyces antibioticus
Figure S3. TLC profile of crude extraction from the cultures. (1) Control experiment without adding of substrate, (2) and (3) Crude extract of feeding experiment with apigenin and baicalein, respectively.
Figure S4. High-performance liquid chromatography (HPLC) elution profiles of the crude extracts. (A) Crude extract of apigenin - fed experiment displaying the retention time of apigenin at 9.4 min and APG at 5.2 min. (B) In the similar manner, crude extract of baicalein-fed experiment showing the peak of baicalein at 9.2 min and BCG at 5.3 min.
Figure S5. Prep-HPLC profile of crude extract.(A) apigenin-fed E. coli extract, and (B) baicalein-fed E. coliextract.
Figure S6. HPLC profile of purified flavone glucosides. (A) apigenin-7-O-β-glucoside (APG), and (B) baicalein-7-O-β-glucoside. Purity was monitored by the area percent (%).
Figure S7. LC-QTOF-ESI/MS profile. (A) apigenin-7-O-glucoside and (B) baicalein-7-O-
glucoside.
Figure S8. (A) 1H NMR spectrum of BCG, and (B) 13C NMR spectrum of BCG.
Figure S9. (A) 1H NMR spectrum of APG, (B)13C NMR spectrum of APG.
Figure S10. (A) HMBC spectrum of APG, (B) HMBC spectrum of BCG
73
74
75
76
777879
8081828384858687
888990
91929394
9596
9798
99
100
101
102
103
Figure S11. SDS-PAGE analysis of protein expression. Lane 1, protein marker ; Lane 2, Insoluble fraction; Lane 3: Soluble fraction. The apparent mass of protein is about 63,7 kDa.
Figure S12. Production of glucoside by the control and mutants. MAFA and MAFB, the controls
were fed with apgenin and baicalein, respectively. Similarly, MA1FA, MA2FA, MA3FA;
MA1FB, MA2FB and MA3FB: strains MA1F, MA2F and MA3F were transformed with
apigenin and baicalein, respectively. The experiments were performed in triplicate and repeated
three times. Error bars indicate standard deviations.
Figure S13. (A). Effect of different glucose concentration on the production of BCG using
MA3F strain. GL, GL1, GL2 and GL3 indicated 0, 1, 3 and 5% of glucose-supplemented TB
media using for culture. (B) Effect of different glycerol concentration on the cell growth of
MA3F strain. G, G1, G2 and G3 indicated 0.4, 1, 1.5 and 2% of glycerol-supplemented TB
media. The experiments were performed in triplicate and repeated three times. Error bars
indicate standard deviations.
104105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
Table S1
Type of substrate Names Chemical formula Relative bioconversion rate (%)
Flavone
Apigenin 100
Baicalein 85
Luteolin 23.5
Chrysin 5.5
Flavonol
Quercetin 0
Kaempferol 0
Myricetin
0
Daidzein 0
125
Isoflavone Genistein 0
Flavanone
Naringenin 0
Hesperetin 0
Hesperidin 0
Table S2
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
(A)
Apigenin-7-O-β-glucoside Baicalein-7-O-β-glucoside
Proton Chemical shift
Number of proton
Multiple Coupling constant (J)
Proton Chemical shift
Number of proton
Multiple Coupling constant (J)
3 6.83 1H s 3 7.02 1H s
6 6.44 1H d 8 6 8.60 1H s
8 6.83 1H s 8 7.07 1H s
5 12.98 1H s 5 12.57 1H s
2’,6’ 7.97 2H d 16 2’, 6’ 8.07 2H d 16
3’,5’ 6.95 2H d 16 3’, 4’, 5’ 7.59 - 7.64
3H m
1” 5.15 1H d 8 1” 5.16 1H d 8
4” 3.21 1H m
6” 3.73 1H m
(B)
142
143
144
145
146
147
148
149
150
151
152
153
154
155
Apigenin-7-O-β-glucoside Baicalein-7-O-β-glucoside
Carbon Chemical shift Carbon Chemical shift
C-4 182.48 C-4 183.05C-2 164.72 C-2 163.94C-9 163.43 C-9 152.09C-7 161.85 C-7 149.68C-5 161.58 C-5 146.95C-4’ 157.41 C-4’ 132.55C-6 129.09 C-6 131.30C-1’ 121.49 C-1’ 131.06
C-5’ 116.47 C-5’ 130.06C-3’ 116.47 C-3’ 130.06C-2’ 105.80 C-2’ 126.86C-6’ 105.80 C-6’ 126.86C-10 103.58 C-10 106.56C-3 100.35 C-3 105.20C-1” 99.98 C-1” 101.40C-8 95.30 C-8 94.71C-3” 77.64 C-3” 77.81C-5” 76.90 C-5” 76.34C-2” 73.56 C-2” 73.65C-4” 70.00 C-4” 70.13
C-6” 61.06 C-6” 61.10
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
Figure S1172
173
174
Figure S2
Figure S3
175
176
177
178
179
180
181
182
183
184
Figure S4
(A)
(B)
185
186
187
188
189
190
Figure S5
(A)
(B)
191
192
193
194
195
196
197
Figure S6
(A)
(B)
198
199
200
201
202
203
Figure S7
(A)
(B)
OHO
OOH
OH
OO
OOH
OOH
HOHO OH
OH
204
205
206
207
208
209
210
211
Figure S8
(A)
(B)
212
213
214
215
216
217
218
219
220
221
Figure S9
(A)
(B)
222
223
224
225
226
227
228
229
Figure S10
(A)
(B)
230
231
232
233
234
235
236
237
238
239
240
241
Figure S11
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
Figure S12
12 h 24 h 36 h 48 h 60 h0
5
10
15
20
25
MAFAMAFBMA1FAMA1FBMA2FAMA2FBMA3FAMA3FB
Incubation time (h)
Prod
uct (
mgL
-1)
Figure S13
(A)
12 h 24 h 36 h 48 h 60 h0
5
10
15
20
25
GLGL1GL3GL2
Incubation time (h)
Prod
uct (
mg/
L)
261
262
263
264
265
266
267
268
269
270
(B)
12 h 24 h 36 h 48 h 60 h0
5
10
15
20
25
GG1G3G2
Incubation time (h)
Prod
uct (
mg/
L)
References
[1] Markham KR, Ternai B, Stanley R, Geiger H, Mabry TJ. Carbon-13 NMR study of flavonoids-III: Naturally occurring flavonoid glycosides and their acylated derivatives. Tetrahedron 1978;34:1389-1397.
[2] Bubb WA. NMR spectroscopy in the study of carbohydrates: characterizing the structure complexity. Concept in Magnetic Res 2003;19A: 1-19 . DOI 10.1002/cmr.a.10080.
[3] Antri AE, Messouri I, Tlemçani RC, Bouktaib M,Alami RC, Bali BE, LachkaM. Flavone glycosides from Calycotome villosa subsp. intermedia. Molecules 2004; 9: 568-573.
[4] Seki M, Carninci P, Nishiyama Y, Hayashizaki Y, Shinozaki K. Highefficiency cloning of Arabidopsis full-length cDNA by biotinylated CAP trapper. Plant J 1998;15:707-720.
[5] Seki M, Narusaka M, Kamiya A, Ishida J, Satou M, Sakurai T, Nakajima M, Enju A, Akiyama K, Oono Y, Muramatsu M, Hayashizaki Y, Kawai J, Carninci P, Itoh M, Ishii Y, Arakawa T, Shibata K, Shinagawa A, Shinozaki K. Functional annotation of a full-length Arabidopsis cDNA collection. Science 2002;296:141-145.
271
272
273
274
275276277
278279
280281
282283
284285286287
288
289